YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Johnson & Johnson selling stake in Kenvue

Posted online

Johnson & Johnson is selling its remaining stake in Kenvue, the maker of Tylenol and Band-Aids.

Johnson & Johnson's roughly 9.5% stake in Kenvue is being sold to Goldman Sachs and JPMorgan in a debt-for-equity exchange valued at $3.75 billion.

The banks plan to sell the roughly 189.3 million shares.

Read more from Quartz.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Transportation officials discuss $471M Forward 44 initiative

Project work in Springfield corridor will continue into 2031.

Most Read
Update cookies preferences